Mon. Jan 13th, 2025

Delisting of Securities of Evofem Biosciences, Inc.; Creatd Inc.; Molecular Data Inc.; ECMOHO Limited; and ALFI, Inc. from The Nasdaq Stock Market

Oct 26, 2022

NEW YORK , Oct. 26, 2022 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock of Evofem Biosciences, Inc. Evofem Biosciences, Inc.’s common stock was suspended on August 11, 2022 , and has not traded on Nasdaq since that time.

Related Post

Opinion | The Old World Is Breaking Down. A New One Is Breaking Through.

Jan 12, 2025

Delisting of Securities of BIMI International Medical Inc.; The Dixie Group, Inc.; Clover Leaf Capital Corp.; Focus Impact BH3 Acquisition Company; Forza X1, Inc.; Vertex Energy, Inc; Slam Corp.; and HHG Capital Corporation from The Nasdaq Stock Market

Jan 10, 2025

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 31, 2024

Jan 10, 2025

News You May Have Missed

Jack Smith, Who Led Prosecutions of Trump, Resigns

Jan 12, 2025

Photograph Revives Ukraine-Russia Culture War

Jan 12, 2025

Opinion | How to Survive January

Jan 12, 2025

News Stock Market and Investing

Opinion | The Old World Is Breaking Down. A New One Is Breaking Through.

Jan 12, 2025